Type I interferon antagonism of the JMJD3-IRF4 pathway modulates macrophage activation and polarization.
Kevin Ming-Chin Lee; Adrian A Achuthan; David P De Souza; Tanya J Lupancu; Katrina J Binger; Man K S Lee; Yangsong Xu; Malcolm J McConville; Nicole A de Weerd; Dragana Dragoljevic; Paul J Hertzog; Andrew J Murphy; John A Hamilton; Andrew J Fleetwood
Abstract
Metabolic adaptations can directly influence the scope and scale of macrophage activation and polarization. Here we explore the impact of type I interferon (IFNβ) on macrophage metabolism and its broader impact on cytokine signaling pathways. We find that IFNβ simultaneously increased the expression of immune-responsive gene 1 and itaconate production while inhibiting isocitrate dehydrogenase activity and restricting α-ketoglutarate accumulation. IFNβ also increased the flux of glutamine-derived carbon into the tricarboxylic acid cycle to boost succinate levels. Combined, we identify that IFNβ controls the cellular α-ketoglutarate/succinate ratio. We show that by lowering the α-ketoglutarate/succinate ratio, IFNβ potently blocks the JMJD3-IRF4-dependent pathway in GM-CSF and IL-4 activated macrophages. The suppressive effects of IFNβ on JMJD3-IRF4-dependent responses, including M2 polarization and GM-CSF-induced inflammatory pain, were reversed by supplementation with α-ketoglutarate. These results reveal that IFNβ modulates macrophage activation and polarization through control of the cellular α-ketoglutarate/succinate ratio.
| Journal | CELL REPORTS |
| ISSN | 2211-1247 |
| Published | 19 Apr 2022 |
| Volume | 39 |
| Issue | 3 |
| Pages | 110719 |
| DOI | 10.1016/j.celrep.2022.110719 |
| Type | Journal Article | Research Support, Non-U.S. Gov't |
| Sponsorship |